C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01)
Patent
CA 2737141
The present invention discloses a method for discriminating between sensitive and resistant tumours to a treatment with EGFR inhibitor drugs comprising: in vitro testing whether tumour material expresses the hMena+11a splicing variant of hMe-na, the tumour positive to said testing being sensitive to the treatment.
La présente invention concerne un procédé destiné à différencier des tumeurs résistantes de tumeurs sensibles à un traitement avec des médicaments inhibiteurs de lEGFR, consistant à : tester in vitro si la matière tumorale exprime la variante d'épissage de hMena, une tumeur positive audit test étant sensible au traitement.
Di Modugno Francesca
Nistico Paola
Pino Maria Simona
Fetherstonhaugh & Co.
Istituti Fisioterapici Ospitalieri (ifo) - Istituto Regina Elena
LandOfFree
Human mena isoforms serve as markers of epithelial to... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human mena isoforms serve as markers of epithelial to..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human mena isoforms serve as markers of epithelial to... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1376332